Case report reveals very late thrombosis in a patient with myocardial infarction, suggesting complications of drug-coated balloons.
Evidence underlying the use of drug-coated balloons (DCBs) as an alternative to drug-eluting stents in coronary de novo lesions is poor. We present a case of a 72-year-old man with an ST-elevation myocardial infarction due to very late thrombosis of a lesion previously treated with DCB in the context of an ST-elevation myocardial infarction. Long-term outcomes of DCBs in coronary percutaneous intervention have not been fully explored. Despite the concept of leaving nothing behind, we herein show a very late lesion thrombosis after DCB treatment. Very late thrombosis after the use of DCBs in de novo coronary lesions should be considered as a potential complication with subsequent clinical consequences, especially when large coronary vessels are involved.
No takes yet. Share an insight, caveat, or question.
Gutiérrez et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: